Coffee: Pour Another Cup, Guilt-Free
December 6, 2016
Hepatitis C Doesn’t Have to be a Life Sentence
December 7, 2016
Show all

Bryan Bickell, Former Blackhawk, Diagnosed with Multiple Sclerosis

Former Chicago Blackhawks player, Bryan Bickell, has been diagnosed with multiple sclerosis..

Late last week it was announced that former Chicago Blackhawks forward Bryan Bickell, 30, has been diagnosed with multiple sclerosis. Bickell, who won three Stanley Cup Championships with the Blackhawks, now plays for the Carolina Hurricanes.

“Since the 2015 playoffs, I’ve been struggling to understand what’s been going on with my body,” Bickell said in a statement. “Again during the past few weeks, it felt like something wasn’t right.”

During the 2015 Stanley Cup playoffs, Bickell developed several health issues including vertigo, according to the Chicago Tribune. More recently Bickell said he felt a shooting pain in his shoulder that didn’t subside and spread to his leg after a couple of days.

“Everybody knows your (own) body and what’s normal, what’s not normal,” Bickell told the Tribune. “This was definitely not normal.”

After undergoing various tests, Bickell was diagnosed with multiple sclerosis, an inflammatory disease of the central nervous system that can be potentially disabling.

The cause of the disease is unknown but clinicians believe certain people are genetically predisposed to develop MS. Environmental factors that have yet to be identified may also trigger the disease, according to Dr. Arthur Itkin, a neurologist at Advocate Christ Medical Center’s Neurosciences Institute in Oak Lawn.

Read full article: Bryan Bickell, Former Blackhawk, Diagnosed with Multiple Sclerosis | Chicago Tonight | WTTW

Read Full Article: Bryan Bickell, Former Blackhawk, Diagnosed with Multiple Sclerosis | Chicago Tonight | WTTW

The health and medical information on our website is not intended to take the place of advice or treatment from health care professionals. It is also not intended to substitute for the users’ relationships with their own health care/pharmaceutical providers.

Comments are closed.